Cargando…
Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer
Clinical screening using the National Comprehensive Cancer Network (NCCN) testing criteria may fail to identify all patients with hereditary breast and ovarian cancers. Thus, this study aimed to evaluate the strategy of expanding target patients for genetic testing among Japanese patients. We review...
Autores principales: | Haneda, Eri, Sato, Ann, Suganuma, Nobuyasu, Sebata, Yoshiko, Okamoto, Saki, Toda, Soji, Kohagura, Kaori, Matsubara, Yuka, Sugawara, Yuko, Yamanaka, Takashi, Yamashita, Toshinari, Shimizu, Satoru, Narimatsu, Hiroto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140389/ https://www.ncbi.nlm.nih.gov/pubmed/35627717 http://dx.doi.org/10.3390/ijerph19106182 |
Ejemplares similares
-
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study
por: Sato, Ann, et al.
Publicado: (2021) -
Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018) -
A Large Substernal Goiter that Extended to Both Sides of the Thorax
por: Nakayama, Hirotaka, et al.
Publicado: (2018) -
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis
por: Yamazaki, Haruhiko, et al.
Publicado: (2018) -
A case of undifferentiated pleomorphic sarcoma of the breast with lung and bone metastases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)